Largest health care companies — Page 11
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1001 | Virax Biolabs GroupVRAX | $1.57M | $1.17 | -2.92% | United Kingdom |
| 1002 | OragenicsOGEN | $1.55M | $0.34 | -7.50% | United States |
| 1003 | Kairos PharmaKAPA | $1.55M | $0.46 | -6.74% | United States |
| 1004 | Lakewood-Amedex BiotherapeuticsLABT | $1.42M | $0.60 | +213.48% | United States |
| 1005 | Karyopharm TherapeuticsKPTI | $1.40M | $0.06 | -15.50% | United States |
| 1006 | Agape ATPATPC | $1.34M | $1.34 | -10.07% | Malaysia |
| 1007 | PMGCELAB | $1.32M | $1.63 | -15.06% | United States |
| 1008 | Biodexa PharmaceuticalsBDRX | $1.26M | $2.41 | -10.41% | United Kingdom |
| 1009 | Scinai ImmunotherapeuticsSCNI | $1.21M | $0.46 | +2.50% | Israel |
| 1010 | Flyte AviationVJET | $1.20M | $0.57 | +2.21% | United States |
| 1011 | Artelo BiosciencesARTL | $1.16M | $2.12 | -6.61% | United States |
| 1012 | Matinas BioPharmaMTNB | $1.10M | $1.12 | -5.88% | United States |
| 1013 | Bone BiologicsBBLG | $1.09M | $0.32 | -8.97% | United States |
| 1014 | Valion BioVBIO | $1.07M | $0.49 | -4.35% | United States |
| 1015 | 22nd Century GroupXXII | $1.05M | $1.91 | -21.60% | United States |
| 1016 | IM CannabisIMCC | $965.4K | $0.59 | -18.25% | Canada |
| 1017 | CDT EquityCDT | $881.5K | $0.04 | -14.93% | United States |
| 1018 | SciSparcSPRC | $869.4K | $0.42 | -17.58% | Israel |
| 1019 | ProfusaPFSA | $339.2K | $0.56 | -9.24% | United States |
Showing 1,001–1,019 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.